HIV community supports rapid OTC testing

Who's Positive, a national HIV awareness organization, today announced the results of a year-long online survey measuring support for over-the counter (OTC) HIV testing. The organization will present these results at the upcoming U.S. Food and Drug Administration (FDA) Blood Products Advisory Committee (BPAC) on May 15, 2012.

Overall, the survey findings demonstrate support for rapid OTC testing - particularly from the HIV community - with approximately half of the respondents identified as people living with HIV/AIDS.

The survey gathered responses from 1,569 participants, 74% of which said that they would support an OTC rapid, oral swab HIV test that could be purchased in a retail store, if approved by the FDA. Other key findings include:

  • 66% of the respondents who identify as a HIV-positive consumer support an OTC HIV test

  • 80% of those aged to 30 support an OTC HIV test

  • A majority or nearly 52% of those who identified as a paid member of an HIV/AIDS organization support an OTC HIV test

  • 47% of those who identify as one who performs HIV testing support an HIV OTC test


"Our survey demonstrates widespread support for additional testing options, especially among younger generations and those who are already living with HIV," said Tom Donohue, Founding Director of Who's Positive. "Over-the-counter testing has the potential to break down barriers and empower people who have never been tested before to learn their HIV status and, if positive, find the care and support they need."

Source:

 Who's Positive

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study shows safety of kidney transplants among those with HIV infections